Investigation of the immunologically active constituent of serum of patients with carcinoma.
D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D009369:Neoplasms / Q000276:immunology*; D010455:Peptides / Q000097:blood*; D044967:Serum
D007004:Hypoglycemic Agents; D010455:Peptides
ANTIDIABETICS/therapeutic use; NEOPLASMS/immunology; PEPTIDES/in blood
Br Med J. 1958 Feb 15;1(5067):368-70
13499952
Lancet. 1953 Mar 21;1(6760):568-70
13036077
Biochem J. 1955 Feb;59(2):340-5
14351203
Biochem J. 1928;22(3):826-9
16744086
Adv Cancer Res. 1953;1:503-48
13057711